BOSTON – Tapering but perhaps not completely stopping tumor necrosis factor inhibitors can result in good control of rheumatoid arthritis with considerable cost savings, according to investigators in...
Daily rosuvastatin did not decrease fracture risk in a large international clinical trial involving older men and women who had elevated CRP levels, according to a report published online Dec. 1 in...
Complete endoscopic mucosal resection is an effective, durable, and relatively safe treatment for Barrett’s esophagus with high-grade dysplasia, findings from a series of 107 patients suggest.
A...
Higher serum concentrations of infliximab are associated with clinical response, mucosal healing, and clinical remission in adults with moderate to severe ulcerative colitis, according to post hoc...
Administration of a novel fatty acid–bile acid conjugate safely and significantly reduced liver fat content in patients with nonalcoholic fatty liver disease in a phase II trial.
Administration of...
The outbreak of Ebola virus disease affecting West Africa continues. ECDC provides a weekly update on the evolving situation.
-- Delivered by Feed43 service
The Centers for Medicare & Medicaid Services has begun the process of considering coverage of screening for cervical cancer with human papillomavirus testing.
The agency announced Nov. 25 it has...
BOSTON – A nonsteroidal investigational drug that acts on the glucocorticoid receptor was superior to placebo and noninferior to higher-dose prednisone in adults with rheumatoid arthritis,...
SILVER SPRING, MD. – A Food and Drug Administration advisory panel recommended that a contraindication or warning be added to the labels of injectable corticosteroids, specifically pertaining to...
BOSTON – Golimumab was significantly better than placebo at reducing disease activity and inflammation in patients with nonradiographic axial spondyloarthritis, but only among those who were positive...